Skin Composition for UV Irritation Relief and Sebum Suppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Skin irritation and excessive sebum production are exacerbated by UV exposure and hormonal changes, leading to skin troubles such as acne and oily skin, with existing solutions causing side effects like skin irritation.
Innovation Solution
A composition containing a compound represented by Chemical Formula 1, its salts, stereoisomers, hydrates, or solvates, is used to alleviate skin irritation and suppress sebum production by reducing intracellular lipid synthesis and inflammatory factor expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If retinoic acid or existing sebum suppression materials are used, then sebum production is reduced, but skin irritation occurs as a side effect
Solution Approach 1:
The patent changes the chemical structure parameters of existing retinoid compounds to create a new compound (Compound 1) with modified molecular properties. This structural modification alters the compound's interaction with skin cells, achieving sebum suppression while reducing irritation. The compound contains a specific pyran ring structure with hydroxyl and carbonyl groups at defined positions, which modifies its biological activity profile compared to conventional retinoic acid.
Solution Approach 2:
The patent creates a composite molecular structure combining elements from different known compounds (seletinoid and retinoic acid structures) to form a new hybrid molecule. This composite structure integrates the sebum-suppressing properties of retinoids with reduced irritation characteristics, achieving both desired effects simultaneously through the synergistic combination of structural features.
2Productivity
If materials that strongly suppress lipid metabolism are used, then sebum production decreases, but inflammatory factor expression increases causing skin irritation
Solution Approach 1:
The patent achieves selective action by designing a compound that targets specific cellular pathways locally. Compound 1 selectively inhibits lipid synthesis enzymes (FAS, ACACA) in sebaceous glands while having minimal impact on inflammatory pathways. This localized specificity allows strong sebum suppression without triggering widespread inflammatory responses, as the compound's molecular structure is optimized for binding to lipid metabolism targets rather than inflammatory mediators.
3Object-affected harmful factors
If conventional UV protection methods are used, then skin irritation from UV exposure is reduced, but existing solutions have limitations in effectiveness and side effects
Solution Approach 1:
The patent converts the potential harm of UV exposure into a beneficial effect by using Compound 1 to enhance skin's natural defense mechanisms. The compound pretreats skin cells before UV exposure, upregulating protective enzymes and antioxidants that neutralize UV-induced free radicals. This approach transforms the stress of UV exposure into an opportunity for the compound to demonstrate its protective and reparative functions, reducing irritation while maintaining effectiveness.
Data Source
AI summary
The disclosure relates to the method for alleviating skin irritation or inhibiting sebum production, which includes administering a composition including a compound represented by Chemical Formula 1, a salt thereof, a stereoisomer thereof, a hydrate thereof, or a solvate thereof as an active ingredient to a subject in need of alleviating skin irritation or inhibiting sebum production, and specifically the composition can alleviate the irritation of the skin stimulated by ultraviolet rays, and more specifically, the composition can alleviate the skin irritation by reducing inflammatory factors in the cells of the skin stimulated by simultaneous stimulation of UVA and UVB ultraviolet rays, and in addition, specifically, it is possible to suppress the sebum production by inhibiting intracellular lipid synthesis with the composition, and more specifically, the sebum production of the skin can be suppressed by reducing the expression level of the factors related to intracellular lipid synthesis with the composition.